Literature DB >> 9200445

Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus.

D E Scott1, I Agranovich, J Inman, M Gober, B Golding.   

Abstract

Allergic responses are characterized by the production of Ag-specific IgE Abs that are dependent upon Th2-mediated T cell help. We determined whether heat-killed Brucella abortus (BA), an inducer of Th1 responses, could influence the allergic Th2-mediated IgE response to OVA adsorbed to alum (O/A). BA plus O/A, but not O/A alone, induced high levels of mRNA for IFN-gamma and IL-12 promptly after injection. Furthermore, initial treatment with BA plus O/A rendered both BALB/c and C57Bl/6 mice incapable of mounting high IgE responses even after repeated challenges with allergen alone. Long term abrogation of anti-OVA IgE correlated with an increased frequency of IFN-gamma-secreting OVA-specific cells and a decreased frequency of IL-4-secreting OVA-specific cells. Initial treatment with anti-IL-12 prevented BA-induced early IFN-gamma production and secondary IgG2a responses, but did not abrogate IgE suppression. Additionally, secondary OVA-specific IgE responses were down-regulated by BA conjugated to OVA or by BA given with O/A. BA-induced down-regulation of secondary IgE responses was associated with increased frequency of Ag-specific IFN-gamma-secreting cells. These results suggest the possibility that even recall Th2-mediated immune responses can be attenuated if Ag is given with a carrier or adjuvant that induces potent Th1-promoting cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200445

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Down-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway.

Authors:  I Agranovich; D E Scott; D Terle; K Lee; B Golding
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Host resistance to Listeria monocytogenes infection is enhanced but resistance to Staphylococcus aureus infection is reduced in acute graft-versus-host disease in mice.

Authors:  T Miura; D Mizuki; S Sasaki; S Hasegawa; H Sashinami; A Nakane
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Systemic mycobacterial infection inhibits antigen-specific immunoglobulin E production, bronchial mucus production and eosinophilic inflammation induced by allergen.

Authors:  X Yang; S Wang; Y Fan; L Zhu
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

4.  Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.

Authors:  Neelima Sanakkayala; Anna Sokolovska; Jatinder Gulani; Harm Hogenesch; Nammalwar Sriranganathan; Stephen M Boyle; Gerhardt G Schurig; Ramesh Vemulapalli
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

5.  Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria.

Authors:  L Huang; A M Krieg; N Eller; D E Scott
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Ontogeny of Th1 memory responses against a Brucella abortus conjugate.

Authors:  O Scharf; I Agranovich; K Lee; N L Eller; L Levy; J Inman; D E Scott; B Golding
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Authors:  R Vemulapalli; Y He; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Vector development for the expression of foreign proteins in the vaccine strain Brucella abortus S19.

Authors:  D J Comerci; G D Pollevick; A M Vigliocco; A C Frasch; R A Ugalde
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  Factors that Influence the Immunological Adjuvant Effect of Lactobacillus fermentum PC1 on Specific Immune Responses in Mice to Orally Administered Antigens.

Authors:  Meera Esvaran; Patricia L Conway
Journal:  Vaccines (Basel)       Date:  2016-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.